Related Experiment Video
Updated: Apr 5, 2026

Technique of Porcine Liver Procurement and Orthotopic Transplantation using an Active Porto-Caval Shunt
Published on: May 7, 2015
Short-Term Effects of Blood Transfusions on Hepcidin in Preterm Infants
Laila Lorenz1, Katharina F Müller, Christian F Poets
1Department of Neonatology, University Children's Hospital of Tx00FC;bingen, Tx00FC;bingen, Germany.
Insights
Red blood cell transfusions increase serum hepcidin (HepS) in preterm infants, but urinary hepcidin (HepU) remains unchanged. Further studies are needed to understand hepcidin regulation dynamics in this population.
Area of Science:
- Neonatal Medicine
- Pediatric Endocrinology
- Hematology
Background:
- Hepcidin is a crucial peptide hormone for iron homeostasis.
- It holds potential as a non-invasive marker for iron status in preterm infants.
- Understanding factors influencing hepcidin is essential for its clinical application.
Purpose of the Study:
- To investigate the immediate impact of red blood cell (RBC) transfusions on hepcidin levels in preterm infants.
- To assess changes in both serum hepcidin (HepS) and urinary hepcidin (HepU) concentrations post-transfusion.
Main Methods:
- A prospective, observational study involving very preterm infants (<32 weeks gestational age).
- Hepcidin concentrations (HepS and HepU) and cellular indices were measured before and after clinically indicated RBC transfusions.
- Measurements utilized competitive enzyme-linked immunosorbent assay.
Main Results:
- Twenty preterm infants received 27 RBC transfusions.
- Hematocrit levels significantly increased post-transfusion (p < 0.0001).
- Serum hepcidin (HepS) concentrations showed a significant increase shortly after transfusion (p < 0.05), while urinary hepcidin (HepU) levels remained unaffected.
Conclusions:
- Serum hepcidin concentrations rise shortly after RBC transfusion in preterm infants.
- Urinary hepcidin does not appear to be affected by short-term RBC transfusions.
- Long-term studies are necessary to elucidate the complex dynamics of hepcidin regulation in preterm infants.
Background:
Hepcidin, a key regulatory peptide hormone in iron homeostasis, may in future serve as a non-invasive iron status parameter for monitoring iron supplementation in preterm infants. For this, coexisting influencing factors should be taken into account.
Objectives:
To evaluate the short-term effects of red blood cell (RBC) transfusions on hepcidin concentrations in serum (HepS) and urine (HepU) of preterm infants.
Methods:
This was a prospective, observational study conducted between May 2009 and September 2010 at a single neonatal unit (Tübingen University Hospital, Tübingen, Germany) in very preterm infants, i.e. with a gestational age (GA) of <32 weeks, who received clinically indicated RBC transfusions. The concentration of the mature, 25 amino-acid form of hepcidin was determined in serum und urine by competitive enzyme-linked immunosorbent assay together with cellular indices before and after transfusion.
Results:
Twenty preterm infants born at a median GA of 26 + 0/7 (interquartile range: 24 + 6/7 to 27 + 3/7) weeks received 27 RBC transfusions at a median corrected age of 31 + 3/7 (29 + 6/7 to 34 + 5/7) weeks. When measured shortly after transfusion (mean time: 10 h), haematocrit values increased from a mean of 26.6% (SD 2.8) to 40.9% (SD 3.2); p < 0.0001. HepS also increased [geometric mean: 44.3 (95% confidence interval 30.8-63.8) ng/ml vs. 58.0 (35.7-94.3) ng/ml; p < 0.05] but HepU remained unaffected.
Conclusion:
The data indicate that HepS concentrations increase shortly after RBC transfusion in preterm infants. Long-term observational studies are needed to understand the dynamics of hepcidin regulation in preterm infants.
More Related Videos
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Rh Blood Group
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Pharmacokinetics in Pediatric Patients: Drug Distribution

